During the past decade, The Queen's Medical Center-Liver Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Queen's Medical Center-Liver Center" are "Chronic Hepatitis" (2 trials), "Hepatitis B" (2 trials), "Hepatitis C, Chronic" (1 trials), "Non Alcoholic Steatohepatitis (NASH)" (1 trials) and "Non-Alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "The Queen's Medical Center-Liver Center" in a lesser frequency.

Most popular intervention types in "The Queen's Medical Center-Liver Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Adefovir" (2 trials), "Clevudine" (2 trials), "Obeticholic Acid" (2 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Queen's Medical Center-Liver Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The Queen's Medical Center-Liver Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Queen's Medical Center-Liver Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Queen's Medical Center-Liver Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".